X. Liem

1.5k total citations · 1 hit paper
51 papers, 854 citations indexed

About

X. Liem is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, X. Liem has authored 51 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Otorhinolaryngology, 26 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in X. Liem's work include Head and Neck Cancer Studies (29 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Advanced Radiotherapy Techniques (10 papers). X. Liem is often cited by papers focused on Head and Neck Cancer Studies (29 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Advanced Radiotherapy Techniques (10 papers). X. Liem collaborates with scholars based in France, Spain and Switzerland. X. Liem's co-authors include Phuc Félix Nguyen‐Tan, Emily Kay‐Rivest, Khalil Sultanem, Jan Seuntjens, Nader Khaouam, Martin Vallières, Hugo J.W.L. Aerts, Issam El Naqa, C Furstoss and Fred Saad and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

X. Liem

45 papers receiving 846 citations

Hit Papers

Radiomics strategies for risk assessment of tumour failur... 2017 2026 2020 2023 2017 100 200 300

Peers

X. Liem
Sweet Ping Ng United States
Myo Min Australia
É. Chajon France
Jonathan E. Leeman United States
X. Sharon Qi United States
Brandon A. Dyer United States
James Wheeler United States
Sweet Ping Ng United States
X. Liem
Citations per year, relative to X. Liem X. Liem (= 1×) peers Sweet Ping Ng

Countries citing papers authored by X. Liem

Since Specialization
Citations

This map shows the geographic impact of X. Liem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Liem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Liem more than expected).

Fields of papers citing papers by X. Liem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. Liem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Liem. The network helps show where X. Liem may publish in the future.

Co-authorship network of co-authors of X. Liem

This figure shows the co-authorship network connecting the top 25 collaborators of X. Liem. A scholar is included among the top collaborators of X. Liem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X. Liem. X. Liem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tourneau, Christophe Le, Zoltán Takácsi‐Nagy, Sandra Nuyts, et al.. (2025). Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC. Future Oncology. 21(12). 1489–1499. 3 indexed citations
2.
Biau, J., Xu-Shan Sun, X. Liem, et al.. (2025). 2449 Postoperative SBRT for Early-Stage Oropharyngeal and Oral Cavity Cancers with High-Risk Margins: the STEREOPOSTOP GORTEC 2017-03 phase 2 trial. Radiotherapy and Oncology. 206. S1028–S1029. 1 indexed citations
3.
Roos, Małgorzata, Marie‐Cécile Le Deley, Dominique Pasquier, et al.. (2024). Multicriteria optimization of radiation therapy: Towards empowerment and standardization of reverse planning for head and neck squamous cell carcinoma. Cancer/Radiothérapie. 28(4). 317–322.
4.
Perrier, Lionel, Frédéric Balusson, J. Castelli, et al.. (2024). Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial. Radiotherapy and Oncology. 193. 110116–110116. 4 indexed citations
5.
Liem, X., Thierry de Baère, Omar I. Vivar, et al.. (2024). International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers. Head & Neck. 46(6). 1253–1262. 10 indexed citations
6.
Castelli, J., Xinzhi Sun, Érik Neveu, et al.. (2024). 852MO REWRITE–GORTEC 2018-02: Radiotherapy-durvalumab without prophylactic neck irradiation in squamous cell carcinoma of the head and neck. Annals of Oncology. 35. S615–S615. 3 indexed citations
7.
Giraud, P, S. Guihard, S. Thureau, et al.. (2024). Prediction of the need of enteral nutrition during radiation therapy for head and neck cancers. Radiotherapy and Oncology. 203. 110693–110693. 1 indexed citations
8.
Blanchard, Pierre, Valentin Calugaru, Alexandre Coutté, et al.. (2024). Proposition de délinéation des volumes cibles anatomocliniques postopératoires de la tumeur primitive des cancers du sinus maxillaire et des cavités nasales. Cancer/Radiothérapie. 28(2). 218–227. 1 indexed citations
9.
Tourneau, C. Le, Zoltán Takácsi‐Nagy, Laetitia Finzi, et al.. (2023). Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final Results of a Phase I Trial. International Journal of Radiation Oncology*Biology*Physics. 117(2). S99–S99. 1 indexed citations
10.
Pasquier, Dominique, et al.. (2023). Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center. Radiotherapy and Oncology. 190. 110029–110029. 2 indexed citations
11.
Guihard, S., P. Giraud, X. Liem, et al.. (2023). Données de vie réelle en radiothérapie : le data farming du groupe Unitrad. Cancer/Radiothérapie. 27(6-7). 455–459.
12.
Hoffmann, Caroline, Valentin Calugaru, Édith Borcoman, et al.. (2021). Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx. European Journal of Cancer. 146. 135–144. 45 indexed citations
13.
Brenet, Esteban, Camille Schiffler, P. Pommier, et al.. (2021). Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: A multicentric study using propensity score. Radiotherapy and Oncology. 160. 1–8. 4 indexed citations
14.
Mirabel, X., F. Crop, T. Lacornerie, et al.. (2021). Radiothérapie du carcinome épidermoïde du larynx de stade précoce, étage glottique : intérêt de l’hypofractionnement ?. Cancer/Radiothérapie. 25(8). 801–810. 1 indexed citations
15.
Giraud, P, Philippe Giraud, M. Alfonsi, et al.. (2020). Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers. Cancers. 13(1). 57–57. 17 indexed citations
16.
Guévelou, Jennifer Le, Vianney Bastit, Pierre Yves Marcy, et al.. (2020). Flap delineation guidelines in postoperative head and neck radiation therapy for head and neck cancers. Radiotherapy and Oncology. 151. 256–265. 13 indexed citations
19.
Pasquier, Dominique, Franck Darloy, L. Gilbeau, et al.. (2016). Harmonization of the Volume of Interest Delineation among All Eleven Radiotherapy Centers in the North of France. PLoS ONE. 11(3). e0150917–e0150917. 4 indexed citations
20.
Liem, X., C. Chira, Alain Fourquet, et al.. (2013). Résultats préliminaires d’une tomothérapie hélicoïdale adjuvante avec boost intégré dans le cadre d’un traitement conservateur d’un cancer du sein. Cancer/Radiothérapie. 18(1). 15–22. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026